...
首页> 外文期刊>Indian Journal of Chemistry, Section B. Organic Including Medicinal >Facile synthesis of alkoxyphthalimide derivatized benzimidazole assembled pyrazoles, pyrimidines and isoxazoles, via common intermediate chalcone
【24h】

Facile synthesis of alkoxyphthalimide derivatized benzimidazole assembled pyrazoles, pyrimidines and isoxazoles, via common intermediate chalcone

机译:通过常见的中间体查尔酮轻松合成烷氧基邻苯二甲酰亚胺衍生的苯并咪唑组装的吡唑,嘧啶和异恶唑

获取原文
获取原文并翻译 | 示例

摘要

In the present investigation, synthesis of 2-(3-aryl-2-phenyl-3,4-dihydropyrazol-5-yl)-1-N-alkoxyphthalimidobenzimid-azole 9a-h, 4-(1-N-alkoxyphthalimidobenzimidazol-2-yl)-6-arylpyrimidin-2-amine 10a-h and 2-(5-aryl-4,5-dihydro-isoxazol-3-yl)-1-N-alkoxyphthalimidobenzirrtidazole 11a-h are described. Mild dichromate oxidation of 1-benzimidazol-2-yl-ethanol 1 gives 1-benzimidazol-2-yl-ethanone 2 which on Clasien condensation with various aromatic aldehydes yields the corresponding 3-aryl-1-(benzimidazol-2-yl)-prop-2-en-1-one 3a-d derivatives. Compound 3a-d act as key intermediates for all the three series of final compounds. In one pathway 3a-d is converted to its alkoxyphthalimide derivatives 5a-h by condensation with ω-bromoalkoxyphthalimides 4a-b, which cyclize with PhNHNH2/pyridine, guanidine nitrate/10% NaOH and hydroxylamine hydrochloride/CH3COOH to give 9a-h, 10a-h and 11a-h respectively. In an alternative route, reaction of 3a-d with all the three reagents affords 2-(3-aryl-2-phenyl-3,4-dihydropyrazol-5-yl)benzimidazole 6a-d, 4-(benzimidazol-2-yl)-6-arylpyrimidin-2-amine 7a-d and 2-(5-aryl-4,5-dihydroisoxazol-3-yl)benzimidazole 8a-d which on condensation with ω-bromoalkoxyphthalimides 4a-b give the final compounds 9a-h, 10a-h and 11a-h. Structure elucidations of all the compounds have been accomplished by elemental analysis, IR, ~1H NMR and mass spectral data.
机译:在本研究中,合成2-(3-芳基-2-苯基-3,4-二氢吡唑-5-基)-1-N-烷氧基邻苯二甲酰亚胺苯并咪唑9a-h,4-(1-N-烷氧基邻苯二甲酰亚胺苯并咪唑-2描述了-(基)-6-芳基嘧啶-2-胺10a-h和2-(5-芳基-4,5-二氢-异恶唑-3-基)-1-N-烷氧基邻苯二甲酰亚胺基苯并咪唑11a-h。 1-苯并咪唑-2-基-乙醇1的重铬酸盐轻度氧化得到1-苯并咪唑-2-基-乙酮2,在与各种芳族醛进行Clasien缩合反应后,生成相应的3-芳基-1-(苯并咪唑-2-基)- prop-2-en-1-一个3a-d衍生物。化合物3a-d充当所有这三个系列最终化合物的关键中间体。在一种途径中,通过与ω-溴代烷氧基邻苯二甲酰亚胺4a-b缩合,将3a-d转化为其烷氧基邻苯二甲酰亚胺衍生物5a-h,后者与PhNHNH2 /吡啶,硝酸胍/ 10%NaOH和羟胺盐酸盐/ CH3COOH环化,得到9a-h,10a -h和11a-h。在替代途径中,3a-d与所有三种试剂反应,得到2-(3-芳基-2-苯基-3,4-二氢吡唑-5-基)苯并咪唑6a-d,4-(苯并咪唑-2-基) )-6-芳基嘧啶-2-胺7a-d和2-(5-芳基-4,5-二氢异恶唑-3-基)苯并咪唑8a-d,它们与ω-溴烷氧基邻苯二甲酰亚胺4a-b缩合,得到最终化合物9a- h,10a-h和11a-h。所有化合物的结构阐明已通过元素分析,IR,〜1H NMR和质谱数据完成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号